NAD+ (Nicotinamide Adenine Dinucleotide) vs Pinealon (EDR)

NAD+ (Nicotinamide Adenine Dinucleotide)

NAD+, nicotinamide adenine dinucleotide, is a non-peptide coenzyme formed from two nucleotides joined through their phosphate groups. One nucleotide carries adenine and the other nicotinamide, a form of vitamin B3, and the molecule occurs in every living cell. Cells can make it from tryptophan or nicotinic acid, but mammalian cells rely mostly on a salvage pathway that recycles nicotinamide, with the enzyme NAMPT setting its pace. Identified in yeast extracts more than a century ago, it has long been central to enzymology; recent work, mostly in rodents and cell culture, concerns its roles in signalling and how its levels change with age and metabolic state. Human data on exogenous NAD+ remain limited.

Pinealon (EDR)

Pinealon is the synthetic tripeptide Glu-Asp-Arg (EDR), one of the short 'bioregulator' peptides described by a Russian research group. That group proposes that very short peptides can act on gene expression directly, without a conventional receptor, a view that has had little independent testing. Most published work on Pinealon comes from the same group and its collaborators. It consists of experiments in cultured neurons and other cells, rodent studies centred on the nervous system and oxidative stress, and computer modelling of how the peptide might bind DNA. Human data are very limited.

How NAD+ (Nicotinamide Adenine Dinucleotide) acts

NAD+ accepts a hydride ion to become NADH, and the NAD+/NADH pair carries electrons from glycolysis and mitochondrial dehydrogenases to complex I of the respiratory chain. Beyond this redox role, three enzyme families consume NAD+ as a substrate: the sirtuins, which remove acetyl and other acyl groups from proteins; the poly(ADP-ribose) polymerases (PARPs), which are activated by DNA strand breaks; and CD38 and related enzymes, which generate signalling molecules such as cyclic ADP-ribose. NAD+ outside cells is generally thought to be broken down by cell-surface enzymes into smaller precursors before cells take it up, so the fate of exogenous NAD+ is itself a research question.

How Pinealon (EDR) acts

The originating group has proposed that EDR enters cells and their nuclei and binds particular DNA sequences or histone proteins, changing the expression of nearby genes. Support for this comes mainly from molecular modelling and in vitro binding experiments. In cultured neurons and other cells exposed to oxidative stress, Pinealon has been reported to lower the accumulation of reactive oxygen species and to alter ERK1/2 (MAPK) signalling, and rodent studies from the same group have measured markers of oxidative damage in brain tissue. No specific receptor for the peptide has been identified, and independent confirmation of these mechanisms is limited.

The records side by side

• Type: NAD+ (Nicotinamide Adenine Dinucleotide), Coenzyme (dinucleotide); Pinealon (EDR), Tripeptide
• Length: NAD+ (Nicotinamide Adenine Dinucleotide), not recorded; Pinealon (EDR), 3 amino acids
• Molecular weight: NAD+ (Nicotinamide Adenine Dinucleotide), 663.4 g/mol; Pinealon (EDR), 418.40 g/mol
• Molecular formula: NAD+ (Nicotinamide Adenine Dinucleotide), C21H27N7O14P2; Pinealon (EDR), C15H26N6O8

Reading a comparison

A comparison places two records side by side; it does not merge them. Each description above is drawn from that compound's own record, and the two were not necessarily characterised by the same methods, at the same time, or to the same level of detail. Before comparing any attribute, it is worth establishing that both records describe the substance you think they describe — names are not identifiers, and two entries sharing a name can differ in salt form, stereochemistry or the convention used to state a mass. Where a figure carries no method beside it, the comparison is between two reported numbers rather than between two measurements.